For immediate release
Chicago, IL – July 8, 2021 – Zacks.com announces the list of stocks featured on the Analysts Blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and financial markets. Stocks recently featured on the blog include: Shopify Inc. SHOP, Lowe’s Companies, Inc. LOW, CVS Health Corporation CVS, Moderna, Inc. MRNA, and The Bank of New York Mellon Corporation BK.
Here are highlights from Wednesday’s analyst blog:
Top Research Reports for Shopify, Lowe’s, and CVS Health
Zacks Research Daily features the best research results from our team of analysts. Today’s Research Daily features new research reports on 16 major stocks, including Shopify, Lowe’s Companies, and CVS Health. These research reports were handpicked from the roughly 70 reports released by our team of analysts today.
You can see all today’s research reports here >>>
Actions of Shopify outperformed Zacks’ Internet service industry in the period since the start of the year (+ 35.9% vs. + 35.4%). Zacks analyst believes the company is benefiting from the growth driven by the e-commerce boom in the merchant base. Additionally, a slight increase in Shopify Shipping, Shopify Payments, and Shopify Capital drove revenue higher.
In addition, the solid adoption of new merchant-friendly applications is promising. In addition, partnerships with Facebook and Google are expected to broaden the merchant base. However, higher investments in product development and the fulfillment platform amid fierce competition in e-commerce are expected to limit margin expansion in the near term.
(You can read the full Shopify research report here >>>)
Lowe’s stocks have gained + 18.8% in the past six months against the Zacks Building Products – Retail industry gain of + 15.3%. Zacks analyst believes the company remains well positioned to capitalize demand in the home improvement market, supported by investments in technology, merchandise category and the strength of the Pro business.
In addition, its new complete home strategy which includes providing complete solutions for various types of home repair and improvement needs bodes well. Strategy is an extension of the company’s retail fundamentals approach. In addition, management is also committed to increasing its market share and driving the expansion of operating margin.
(You can read the full research report on Lowe’s here >>>)
Actions of CVS Health have gained + 10.1% in the last three months against the gain of the Zacks Retail Pharmacies and Drug Stores industry of + 3.5%. The Zacks analyst is encouraged by the growing demand for PBMs and specialty pharmacies as well as the significant growth in retail.
Meanwhile, the consumer-centric digital strategy has become more relevant in today’s environment as people use technology more while staying indoors. In the first quarter, the company achieved higher levels of engagement across all digital assets. However, a weak cough, cold and flu season impacted growth in Pharmacy and Retail / LTC Services.
(You can read the full research report on CVS Health here >>>)
Other noteworthy reports we present today include Moderna and The Bank of New York Mellon.
Boom in infrastructure stocks will sweep America
A massive push to rebuild crumbling American infrastructure will soon be underway. It is bipartisan, urgent and inevitable. Billions will be spent. Fortunes will be made.
The only question is, “Are you going to jump into good stocks early when they have the greatest potential for growth?” “
Zacks published a special report to help you do just that, and today it’s free. Discover 7 special companies looking to make the most of the construction and repair of roads, bridges and buildings, as well as transporting goods and transforming energy on an almost unimaginable scale.
Download FREE: How to Profit from Trillions in Infrastructure Spending >>
Zacks investment research
800-767-3771 ext 9339
Past performance is no guarantee of future results. The potential for loss is inherent in any investment. This material is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether an investment is suitable for a particular investor. It should not be assumed that any investment in any identified and described securities, companies, sectors or markets was or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or securities asset management activities. These returns come from hypothetical portfolios composed of stocks with a Zacks rank = 1 that have been rebalanced monthly without any transaction costs. These are not the returns of actual equity portfolios. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for more information on the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today you can download 7 best stocks for the next 30 days. Click to get this free report